CLINICAL_TRIALS
trial_result
· 2018-07-06
Clinical Trial Update: A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia [Phase 3]
Summary
Phase 3 trial evaluating cariprazine for prevention of relapse in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-07-06